Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
OnMay 23, 2019,
the Board of Directors of Cannabis Suisse Corp. (the
) appointed Mr. Alain Parrik (age 23) as the Chief Operating Officer of the Company and as a member of the Board of Directors.
Mr. Parrik is a long-time medical cannabis enthusiast and has consulted various cannabis businesses on a variety of issues related to medical, growing and licensing. From March 2018 to January 2019, Mr. Parrik spent a year in Thailand working as an independent English language teacher. From January 2017 to February 2018, he was employed at Terchest, a language school in Estonia. During this period, he managed to master his communication and nego tiation skills while discussing multiple topics with people of different occupations. From September 2015 to January 2017, Mr. Parrik worked as SMM specialist at PremodCan in Vanier, Canada. The experience he obtained enabled him to gain understanding of the whole process of online promotion and advertising for small and medium businesses. Apart from forgoing, Mr. Alain Parrik has been engaged in medical cannabis family business since June 2011 and assisted his brother in obtaining license for cannabis use in Montreal, Canada. The process of studying and working in the medical cannabis domain inspired him to develop in the field and gain knowledge about CBD-related products. The Board of Directors consider Mr. Parrik
s skills to be valuable for future operations and growth of the Company.
There are no family relationships between our new officer and our sole director. There have been no transactions since the beginning of our last fiscal year, or any currently proposed transaction, in which we were or are to be a participant, exceeding $120,000 and in which our new officer had or will have a direct or indirect material interest. There is no material plan, contract or arrangement (whether or not written) to which our new officer is a party or in which he participates that is entered into or a material amendment in connection with the triggering event or any grant or award to any such covered person or modification thereto, under any such plan, contract or arrangement in connection with any such event. The officer serves in such executive positions at the discretion of the Board of Directors. The Company and its new officer have verbally agreed that no compensation will be due or owning to the new officer until such time as the parties reach a written compensation agreement, if any.
On May 23, 2019 and immediately prior to the above appointment, a majority of shareholders voted to amend the Company by-laws to create the office of Chief Operating Officer. The Chief Operating Officer will report to the Chief Executive Officer and shall perform such duties as instructed from time to time by the Chief Executive Officer.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CANNABIS SUISSE CORP.
Suneetha Nandana Silva Sudusinghe
Chief Executive Officer
Date: May 30, 2019
makes a similar move, sign up!
Other recent filings from the company include the following: